Q12024

Novartis Financial Results–Q12024

Novartis announced the company’s financial results for the first quarter of 2024。

Learn more
Shanelle Gabriel spending time with her father in New York

Novartis in Society Integrated Report2023

This report covers our business，strategy，and performance.It high lights progress against our ESG targets and describes how we create sustainable value for diverse stakeholders.It follows requirements of the Swiss Code of Obligations and various voluntary reporting frameworks and stards。
Team meeting

About Us

At Novartis，we are united by a single purpose to reimagine medicine to improve and extend people’s lives。
不受影响的不受影响的设备生产线

车辆驾驶室，车辆驾驶室，车辆驾驶室

State-of-the-art Novartis manufacturing facility in Indianapolis fortifies the foundation of an entirely new paradigm in pharmaceutical drug delivery。

读数，读数
Scientist in lab

钢管，钢管

Novartis is expanding the Beacon of Hope program through new collaborations to address systemic health disparities。

Learn more
手动headset sitting inside an office smiling

Patient Support for Oncology

Novartis Patient Support for Oncology can help you on treatment。
钢轨内安装面

接触Us

Find information on our research locations and corporate offices in US。
us careers image_0

Careers

769million lives touched by our products。Join us。

Latest News

主252024

Novartis atrasentan Phase III data show clinically meaningful proteinuria reduction further advancing company's IgA nephropathy（IgAN）portfolio

主252024

Novartis presents latest Phase III Fabhalta®（iptacopan）data in C3glomerulopathy（C3G）showing clinically meaningful and statistically significant35.1%proteinuria reduction vs.placebo

主152024

Novartis high lights pioneering innovation in CML with data from Scemblix®Phase III ASC4 FIRST study in newly diagnosed patients at ASCO and EHA
查看，查看